Type IV Collagen Mutations in Familial IgA Nephropathy-Reference-Cited by-同舟云学术

Type IV Collagen Mutations in Familial IgA Nephropathy

Published:2020-07 Issue:7 Volume:5 Page:1075-1078
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Li Yifu,Groopman Emily E.,D’Agati Vivette,Prakash Sindhuri,Zhang Junying,Mizerska-Wasiak Malgorzata,Caliskan Yasar,Fasel David,Karnib Hussein H.,Bono Luisa,Omran Sadek Al,Sabban Essam Al,Kiryluk Krzysztof,Caridi Gianluca,Ghiggeri Gian Marco,Sanna-Cherchi Simone,Scolari Francesco,Gharavi Ali G.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Nephrology

Reference9 articles.

1. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy;Magistroni;Kidney Int,2015

2. IgA nephropathy;Wyatt;N Engl J Med,2013

3. Thin basement membrane disease in patients with familial IgA nephropathy;Frasca;J Nephrol,2004

4. Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36;Paterson;J Am Soc Nephrol,2007

5. Expert consensus guidelines for the genetic diagnosis of Alport syndrome;Savige;Pediatr Nephrol,2019

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Significance of the Cystic Phenotype in Alport Syndrome;American Journal of Kidney Diseases;2024-09

2. Alport Syndrome;Advances in Kidney Disease and Health;2024-05

3. X-linked Alport syndrome presenting in mother and son with the same unique histopathological features;Journal of Nephrology;2024-04-26

4. Progress in therapeutic targets on podocyte for Alport syndrome;Journal of Translational Internal Medicine;2024-04-01

5. Alport syndrome and Alport kidney diseases – elucidating the disease spectrum;Current Opinion in Nephrology & Hypertension;2024-03-13